We have thus synthesized the human ERα-derived peptide PLMIKRSKKNSLALSLT (ERα17p, residues 295 to 311) and tested its effects in different experimental conditions and in various ERα-positive (ERα+) and -negative (ERα−) breast cancer cell lines. This evidence concerns the gene ESR1 and breast carcinoma.